Summary & Overview
CPT 87279: Parainfluenza Antigen Detection by Immunofluorescence
CPT code 87279 represents a laboratory immunofluorescent assay to detect antigens of a single Parainfluenza virus type. This targeted diagnostic test supports rapid identification of parainfluenza infection, informing clinical management and infection control decisions in hospitals and outpatient laboratories. Nationally, accurate coding of antigen detection procedures is important for claims adjudication, epidemiologic surveillance, and resource planning.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for antigen-based parainfluenza testing, common sites of service, and the role of this procedure in diagnostic workflows. The publication also summarizes typical coverage considerations and coding-related administrative notes relevant to laboratory services.
This report provides benchmarks and coding guidance context, highlights any recent policy updates affecting laboratory diagnostic billing where available, and explains how CPT code 87279 fits within broader viral testing strategies. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 87279 describes a laboratory procedure in which a lab analyst detects antigens of a single type of Parainfluenza virus using immunofluorescent antibody staining and fluorescence microscopy. This is a targeted viral antigen detection assay performed by trained laboratory personnel.
-
Service type: Laboratory diagnostic test — antigen detection using immunofluorescence
-
Typical site of service: Clinical laboratory or hospital laboratory with fluorescence microscopy capability
Clinical & Coding Specifications
Clinical Context
A typical patient is a pediatric or adult presenting to an outpatient clinic, urgent care, emergency department, or hospital laboratory with acute respiratory symptoms such as fever, cough, nasal congestion, sore throat, wheeze, or increased work of breathing during parainfluenza season. A clinician collects a nasopharyngeal swab or aspirate and sends the specimen to the clinical laboratory. A microbiology technologist or lab analyst performs an antigen detection test for a single type of Parainfluenza virus using an immunofluorescent antibody (IFA) stain and fluorescence microscopy. Results are documented in the laboratory information system and communicated to the ordering clinician to guide infection control, cohorting, antiviral decisions, or further molecular testing if needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only for the professional interpretation and report of the immunofluorescent test separate from the technical component. |
TC | Technical component | Use when billing only for the technical component (laboratory processing, staining, microscopy) and not the professional interpretation. |